We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$7.38B
AUM Growth
+$231M
Cap. Flow
+$238M
Cap. Flow %
3.22%
Top 10 Hldgs %
23.76%
Holding
443
New
26
Increased
211
Reduced
155
Closed
11

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$135M
2
PEP icon
PepsiCo
PEP
+$65.3M
3
PNC icon
PNC Financial Services
PNC
+$61.9M
4
HD icon
Home Depot
HD
+$55.7M
5
HAS icon
Hasbro
HAS
+$48M

Top Sells

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$80.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$67.1M
3
USB icon
US Bancorp
USB
+$65.3M
4
MCD icon
McDonald's
MCD
+$50.1M
5
OKE icon
Oneok
OKE
+$49.8M

Sector Composition

Rank Sector Weight
1 Healthcare 16.18%
2 Consumer Staples 15.63%
3 Technology 14.71%
4 Financials 12.61%
5 Industrials 11.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEL icon
301
TE Connectivity
TEL
$62.6B
$480K 0.01%
6,697
+70
+1% +$4.81K
GK
302
DELISTED
G&K Services Inc
GK
$477K 0.01%
6,570
+190
+3% +$13.5K
IFF icon
303
International Flavors & Fragrances
IFF
$21.7B
$476K 0.01%
4,052
ETP
304
DELISTED
Energy Transfer Partners, L.P.
ETP
$473K 0.01%
11,435
LWAY icon
305
Lifeway Foods
LWAY
$475M
$472K 0.01%
22,088
+755
+4% +$14.4K
GME icon
306
GameStop
GME
$8.57B
$468K 0.01%
49,320
+19,240
+64% +$181K
POWI icon
307
Power Integrations
POWI
$3.6B
$468K 0.01%
17,982
+510
+3% +$13.7K
CB icon
308
Chubb
CB
$135B
$466K 0.01%
4,180
+580
+16% +$65.2K
ALOG
309
DELISTED
Analogic Corp
ALOG
$462K 0.01%
5,086
-2,145
-30% -$185K
SYNT
310
DELISTED
Syntel Inc
SYNT
$450K 0.01%
8,707
-8,050
-48% -$383K
CMCSK
311
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$447K 0.01%
7,977
VNQ icon
312
Vanguard Real Estate ETF
VNQ
$39B
$441K 0.01%
+5,230
New +$444K
CBU icon
313
Community Bank
CBU
$3.42B
$440K 0.01%
+12,445
New +$440K
ATO icon
314
Atmos Energy
ATO
$29B
$439K 0.01%
+7,940
New +$437K
TMO icon
315
Thermo Fisher Scientific
TMO
$217B
$431K 0.01%
3,206
+966
+43% +$125K
HY icon
316
Hyster-Yale Materials Handling
HY
$660M
$428K 0.01%
5,844
+155
+3% +$10.5K
HUB.A
317
DELISTED
HUBBELL INC CL-A
HUB.A
$423K 0.01%
4,000
VMI icon
318
Valmont Industries
VMI
$9.58B
$422K 0.01%
3,433
+95
+3% +$11.6K
MATW icon
319
Matthews International
MATW
$731M
$418K 0.01%
8,118
+245
+3% +$11.8K
AVY icon
320
Avery Dennison
AVY
$13.5B
$417K 0.01%
7,883
-1,595
-17% -$84.4K
CNL
321
DELISTED
CLECO CRP (HOLDING CO)
CNL
$409K 0.01%
7,500
-1,000
-12% -$54.4K
MYGN icon
322
Myriad Genetics
MYGN
$309M
$408K 0.01%
11,511
+430
+4% +$15.4K
FIS icon
323
Fidelity National Information Services
FIS
$21.9B
$407K 0.01%
5,973
EWH icon
324
iShares MSCI Hong Kong ETF
EWH
$1.22B
$395K 0.01%
18,000
SNY icon
325
Sanofi
SNY
$104B
$392K 0.01%
7,929
+610
+8% +$29.2K

Similar funds

Bahl & Gaynor's Q1 2015 Portfolio in Review

As of Q1 2015, Bahl & Gaynor held 443 positions worth $7.38B, up 3.2% from $7.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Bahl & Gaynor deployed $238M of net new capital in Q1 2015, opening 26 new positions and adding to 211 existing holdings. Its largest new stake was Blackstone: 24,777 shares worth $946K.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Technology.

On the sell side, the largest reduction was Baxter International, an estimated $80.6M trimmed.

  • Bahl & Gaynor's largest Q1 2015 buy was Blackstone: 24,777 shares worth $946K.
  • Bahl & Gaynor added most to Pfizer in Q1 2015, an estimated $135M increase.
  • Bahl & Gaynor's biggest Q1 2015 reduction was Baxter International, cutting an estimated $80.6M.
  • Bahl & Gaynor fully exited MWI VETERINARY SUPPLY, INC. in Q1 2015, selling an estimated $650K.
  • Bahl & Gaynor's ten largest holdings make up 24% of its $7.38B portfolio in Q1 2015.
  • Bahl & Gaynor opened 26 new positions and closed 11 in Q1 2015.
  • Bahl & Gaynor's portfolio value rose 3.2% quarter-over-quarter to $7.38B.

Based on Bahl & Gaynor's 13F filing for Q1 2015, filed 12 May 2015.